[1]
Klaassen, Z., Li, K., Kassouf, W., Black, P.C., Dragomir, A. and Kulkarni, G.S. 2017. Contemporary cost-consequence analysis of blue light cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer. Canadian Urological Association Journal. 11, 6 (Jun. 2017), 173–81. DOI:https://doi.org/10.5489/cuaj.4568.